Promus - Registry Experience at the Washington Hospital Center, Drug-eluting Stent (DES)
| Status: | Completed |
|---|---|
| Conditions: | Peripheral Vascular Disease, Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 2/4/2013 |
| Start Date: | October 2009 |
| End Date: | October 2012 |
| Contact: | Rebecca Torguson |
| Email: | rebecca.torguson@medstar.net |
| Phone: | 202-877-2194 |
P-REWARDS (Promus - Registry Experience at the Washington Hospital Center, DES)
Single-center registry of patients treated with at least one Promus, everolimus-eluting,
Stent, with the primary objective to assess clinical success and safety at 30 days, 6 months
and 1 year post-implantation.
Interventional cardiology was revolutionized by the invention of stents, initially with the
bare-metal stents (BMS) and recently with the drug-eluting stents (DES). The everolimus
eluting stents have shown very promising results in randomized clinical trials,
demonstrating a reduction of clinical and angiographic restenosis in comparison to BMS, and
comparable clinically-driven target lesion revascularization rates in comparison with
sirolimus-eluting stents. While registry data is available from outside of the United
States, it will be important to collect "real-world" data regarding the stent usage and
outcomes in the United States. In this study we propose to follow patients who received at
least one Promus® Stent for at least 1 year post initial stent implantation.
Inclusion Criteria:
- Patients, male or female, >18 years of age
- Patients who received at least one Promus drug-eluting stent at the Washington
Hospital Center
Exclusion Criteria:
- N/A
We found this trial at
1
site
110 Irving St NW
Washington, District of Columbia 20010
Washington, District of Columbia 20010
(202) 877-7000
Washington Hosp Ctr MedStar Washington Hospital Center is a not-for-profit, 926-bed, major teaching and research...
Click here to add this to my saved trials
